We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Australian fertility preservation guidelines for people with cancer 2022: review and recommendations.
- Authors
Kieu, Violet; Stern, Catharyn; Harris, Jessica; Jayasinghe, Yasmin; Bradford, Natalie; Cui, Wanyuan; Deans, Rebecca; Hunter, Tamara; Allingham, Catherine; Kane, Stefan C; Lau, Lei Shong; Logan, Shanna; McLachlan, Robert; Neville, Kristen; Peate, Michelle; Phillips, Marianne; Saunders, Carla; Tome, Marianne; Upreti, Rita; White, Kate
- Abstract
Mature oocyte cryopreservation provides a realistic opportunity for future pregnancy for female patients with cancer.[18] The age of the patient and the number of oocytes retrieved will influence the number of opportunities for pregnancy. Fertility preservation treatment is often urgent to prevent a delay in commencing cancer treatments. It is advisable that patients with cancer be offered pre-pregnancy counselling</td><td>III-2</td><td>C</td></tr></tbody></table> ht Effective contraception is required during chemotherapy for women undergoing cancer treatment and immediately after treatment. Women who receive cancer treatment may be more likely to have reduced ovarian reserve than those who have not undergone cancer treatment.[8] Furthermore, sperm quality is reduced in men previously treated for cancer compared with the general population.[9] Azoospermia may occur after cancer treatment including chemotherapy and radiation.
- Subjects
SPERM banks; FERTILITY clinics; FERTILITY preservation; MALE infertility; CANCER relapse; CANCER patients; MEDICAL personnel; FERTILIZATION in vitro; REPRODUCTIVE technology
- Publication
Medical Journal of Australia, 2022, Vol 217, Issue 11, p564
- ISSN
0025-729X
- Publication type
Article
- DOI
10.5694/mja2.51751